BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33082212)

  • 1. Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome.
    Wolska-Kusnierz B; Pastorczak A; Fendler W; Wakulinska A; Dembowska-Baginska B; Heropolitanska-Pliszka E; Piątosa B; Pietrucha B; Kałwak K; Ussowicz M; Pieczonka A; Drabko K; Lejman M; Koltan S; Gozdzik J; Styczynski J; Fedorova A; Miakova N; Deripapa E; Kostyuchenko L; Krenova Z; Hlavackova E; Gennery AR; Sykora KW; Ghosh S; Albert MH; Balashov D; Eapen M; Svec P; Seidel MG; Kilic SS; Tomaszewska A; Wiesik-Szewczyk E; Kreins A; Greil J; Buechner J; Lund B; Gregorek H; Chrzanowska K; Mlynarski W
    Clin Cancer Res; 2021 Jan; 27(2):575-584. PubMed ID: 33082212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and
    Sharapova SO; Pashchenko OE; Bondarenko AV; Vakhlyarskaya SS; Prokofjeva T; Fedorova AS; Savchak I; Mareika Y; Valiev TT; Popa A; Tuzankina IA; Vlasova EV; Sakovich IS; Polyakova EA; Rumiantseva NV; Naumchik IV; Kulyova SA; Aleshkevich SN; Golovataya EI; Minakovskaya NV; Belevtsev MV; Latysheva EA; Latysheva TV; Beznoshchenko AG; Akopyan H; Makukh H; Kozlova O; Varabyou DS; Ballow M; Ong MS; Walter JE; Kondratenko IV; Kostyuchenko LV; Aleinikova OV
    Front Immunol; 2020; 11():602482. PubMed ID: 33488600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective Analysis.
    Wolska-Kuśnierz B; Gregorek H; Chrzanowska K; Piątosa B; Pietrucha B; Heropolitańska-Pliszka E; Pac M; Klaudel-Dreszler M; Kostyuchenko L; Pasic S; Marodi L; Belohradsky BH; Čižnár P; Shcherbina A; Kilic SS; Baumann U; Seidel MG; Gennery AR; Syczewska M; Mikołuć B; Kałwak K; Styczyński J; Pieczonka A; Drabko K; Wakulińska A; Gathmann B; Albert MH; Skarżyńska U; Bernatowska E;
    J Clin Immunol; 2015 Aug; 35(6):538-49. PubMed ID: 26271390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and therapeutic approach to children with Nijmegen breakage syndrome in relation to development of lymphoid malignancies.
    Filipiuk A; Kozakiewicz A; Kośmider K; Lejman M; Zawitkowska J
    Ann Agric Environ Med; 2022 Jun; 29(2):207-214. PubMed ID: 35767752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treosulfan-Based Conditioning Regimen in Haematopoietic Stem Cell Transplantation with TCRαβ/CD19 Depletion in Nijmegen Breakage Syndrome.
    Laberko A; Sultanova E; Gutovskaya E; Radygina S; Deripapa E; Kantulaeva A; Trakhtman P; Brilliantova V; Starichkova J; Shcherbina A; Maschan M; Maschan A; Balashov D
    J Clin Immunol; 2020 Aug; 40(6):861-871. PubMed ID: 32602054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Study of a Cohort of Russian Nijmegen Breakage Syndrome Patients Demonstrating Predictive Value of Low Kappa-Deleting Recombination Excision Circle (KREC) Numbers and Beneficial Effect of Hematopoietic Stem Cell Transplantation (HSCT).
    Deripapa E; Balashov D; Rodina Y; Laberko A; Myakova N; Davydova NV; Gordukova MA; Abramov DS; Pay GV; Shelikhova L; Prodeus AP; Maschan MA; Maschan AA; Shcherbina A
    Front Immunol; 2017; 8():807. PubMed ID: 28791007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful SCT for Nijmegen breakage syndrome.
    Albert MH; Gennery AR; Greil J; Cale CM; Kalwak K; Kondratenko I; Mlynarski W; Notheis G; Führer M; Schmid I; Belohradsky BH
    Bone Marrow Transplant; 2010 Apr; 45(4):622-6. PubMed ID: 19684627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.
    Slack J; Albert MH; Balashov D; Belohradsky BH; Bertaina A; Bleesing J; Booth C; Buechner J; Buckley RH; Ouachée-Chardin M; Deripapa E; Drabko K; Eapen M; Feuchtinger T; Finocchi A; Gaspar HB; Ghosh S; Gillio A; Gonzalez-Granado LI; Grunebaum E; Güngör T; Heilmann C; Helminen M; Higuchi K; Imai K; Kalwak K; Kanazawa N; Karasu G; Kucuk ZY; Laberko A; Lange A; Mahlaoui N; Meisel R; Moshous D; Muramatsu H; Parikh S; Pasic S; Schmid I; Schuetz C; Schulz A; Schultz KR; Shaw PJ; Slatter MA; Sykora KW; Tamura S; Taskinen M; Wawer A; Wolska-Kuśnierz B; Cowan MJ; Fischer A; Gennery AR; ; ; ;
    J Allergy Clin Immunol; 2018 Jan; 141(1):322-328.e10. PubMed ID: 28392333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.
    Groeschel S; Kühl JS; Bley AE; Kehrer C; Weschke B; Döring M; Böhringer J; Schrum J; Santer R; Kohlschütter A; Krägeloh-Mann I; Müller I
    JAMA Neurol; 2016 Sep; 73(9):1133-40. PubMed ID: 27400410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation.
    Gładkowska-Dura M; Dzierzanowska-Fangrat K; Dura WT; van Krieken JH; Chrzanowska KH; van Dongen JJ; Langerak AW
    J Pathol; 2008 Nov; 216(3):337-44. PubMed ID: 18788073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status.
    Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
    Ann Hematol; 2020 Dec; 99(12):2911-2925. PubMed ID: 33000361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day +100 Platelet Count Predicts Survival After Allogeneic Hematopoietic Stem-Cell Transplantation in Children With Hematologic Malignancies.
    Moneib H; Hafez H; Abdalla A; Hassanain O; Lehmann L; Haddad AE
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e221-e227. PubMed ID: 30846344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nijmegen breakage syndrome: case report and review of literature.
    Hasbaoui BE; Elyajouri A; Abilkassem R; Agadr A
    Pan Afr Med J; 2020; 35():85. PubMed ID: 32537088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
    J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare case of primary gastric Hodgkin lymphoma in an adolescent with Nijmegen breakage syndrome.
    Batiuk E; Bassett M; Hakar M; Lin HC; Hunter AK
    BMC Pediatr; 2023 Apr; 23(1):189. PubMed ID: 37085783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network.
    Yonkof JR; Gupta A; Fu P; Garabedian E; Dalal J;
    J Clin Immunol; 2019 May; 39(4):448-458. PubMed ID: 31111420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO).
    Candoni A; Rambaldi A; Fanin R; Velardi A; Arcese W; Ciceri F; Lazzarotto D; Lussana F; Olivieri J; Grillo G; Parma M; Bruno B; Sora F; Bernasconi P; Saccardi R; Foà R; Sessa M; Bresciani P; Giglio F; Picardi A; Busca A; Sica S; Perruccio K; Zucchetti E; Diral E; Iori AP; Colombo AA; Tringali S; Santarone S; Irrera G; Mancini S; Zallio F; Malagola M; Albano F; Carella AM; Olivieri A; Tecchio C; Dominietto A; Vacca A; Sorasio R; Orciuolo E; Risitano AM; Leotta S; Cortelezzi A; Mammoliti S; Oldani E; Bonifazi F;
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2388-2397. PubMed ID: 31400502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell lymphoblastic leukemia/lymphoma in Nijmegen breakage syndrome.
    Pasic S; Vujic D; Fiorini M; Notarangelo LD
    Haematologica; 2004 Aug; 89(8):ECR27. PubMed ID: 15339696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study.
    Lu Y; Zhao YL; Zhang JP; Xiong M; Cao XY; Liu DY; Sun RJ; Wei ZJ; Zhou JR; Lu DP
    Ann Hematol; 2021 Jun; 100(6):1579-1591. PubMed ID: 33236196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair Disorders.
    Buchbinder D; Hauck F; Albert MH; Rack A; Bakhtiar S; Shcherbina A; Deripapa E; Sullivan KE; Perelygina L; Eloit M; Neven B; Pérot P; Moshous D; Suarez F; Bodemer C; Bonilla FA; Vaz LE; Krol AL; Klein C; Seppanen M; Nugent DJ; Singh J; Ochs HD
    J Clin Immunol; 2019 Jan; 39(1):81-89. PubMed ID: 30607663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.